Codexis, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CDXS Nasdaq 2836 www.codexis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Codexis, Inc.

Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS) - Nov 11th, 2025 7:35 am
Codexis Announces Signing of Lease for GMP Manufacturing Facility - Nov 10th, 2025 7:00 am
Codexis Inc (CDXS) Q3 2025 Earnings Call Highlights: Strategic Shifts and New Partnerships ... - Nov 6th, 2025 10:02 pm
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates - Nov 6th, 2025 6:00 pm
Codexis: Q3 Earnings Snapshot - Nov 6th, 2025 4:55 pm
Codexis Reports Third Quarter 2025 Financial Results - Nov 6th, 2025 2:21 pm
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates - Nov 5th, 2025 6:15 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates - Nov 4th, 2025 3:55 pm
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing - Oct 29th, 2025 7:58 am
Codexis to Report Third Quarter 2025 Financial Results on November 6 - Oct 23rd, 2025 5:05 am
Investors in Codexis (NASDAQ:CDXS) have unfortunately lost 79% over the last five years - Sep 25th, 2025 4:40 am
Codexis to Participate in Cantor Global Healthcare Conference - Aug 28th, 2025 7:00 am
Codexis Second Quarter 2025 Earnings: Beats Expectations - Aug 15th, 2025 4:23 am
Codexis Inc (CDXS) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Initiatives - Aug 14th, 2025 1:12 am
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates - Aug 13th, 2025 3:15 pm
Codexis: Q2 Earnings Snapshot - Aug 13th, 2025 2:23 pm
Codexis Reports Second Quarter 2025 Financial Results - Aug 13th, 2025 2:05 pm
[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Aug 13th, 2025 5:30 am
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates - Aug 12th, 2025 1:00 pm
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates - Aug 11th, 2025 6:10 am